IBL HealthCare Limited

IBLHL

PK0095501018

Drug Retailers

End-of-day quote Pakistan S.E. Other stock markets 23:00:00 11/06/2024 BST			5-day change	1st Jan Change
32.79 ^PKR	+0.99%		+3.54%	-9.47%

04-29	IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-26	IBL Healthcare Limited Announces CEO Changes	CI

IBL HealthCare Limited Announces Executive Changes

April 29, 2018

IBL HealthCare Limited announced the Muhammad Tariq has ceased to be the Company Secretary of the company with effect from April 26 2018 and Shariq Zafar has been appointed as Company Secretary.

Latest news about IBL HealthCare Limited

IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-29	CI
IBL Healthcare Limited Announces CEO Changes	04-25	CI
IBL Healthcare Limited Announces Board Changes	04-25	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-29	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	11-01	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/10/23	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2023	06/10/23	CI
IBL HealthCare Limited Announces Executive Changes	26/09/23	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	02/05/23	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	01/03/23	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	27/10/22	CI
IBL HealthCare Limited Reports Earnings Results for the Full Year Ended June 30, 2022	28/09/22	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	27/04/22	CI
IBL HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	28/02/22	CI
IBL HealthCare Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	25/10/21	CI
IBL HealthCare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	29/04/21	CI
Ibl Healthcare Limited Appoints Munis Abdullah and Mobeen Alam as Non-Executive Directors	01/03/21	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	01/03/21	CI
IBL HealthCare Limited Proposes Final Cash Dividend for the Financial Year Ended June 30, 2020	02/10/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2020	01/10/20	CI
IBL HealthCare Limited Appoints Mufti Zia Ul Islam as Chief Executive	18/06/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	19/04/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	27/02/20	CI
Ibl Healthcare Limited Reports Earnings Results for the Full Year Ended June 30, 2019	08/10/19	CI
Ibl Healthcare Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	15/04/19	CI

IBL HealthCare Limited is engaged in marketing, selling and distribution of healthcare products. The Company's product categories include nutrition, health, and wellness, ophthalmic, medical disposables, and pharmaceutical. The nutrition category includes toddlers, baby cereals, medical nutrition, lifestyle nutrition, specialty, and infant formulas. The health and wellness category includes consumer health, and hygiene and safety. The ophthalmic category includes vision care and pharma. The Medical Disposables category consists of renal care, critical care and anesthesia, non-drug, blood transfusion, IV administration, and medical gloves. The Pharmaceutical category consists of various products, such as Seapride, Luxave, Conifa, M-Floxin, Urisolin, Hyplar, Ezcolic, Clariza, and Eprazin. The Company is a subsidiary of The Searle Company Limited and International Brands Limited.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
IBL HEALTHCARE LIMITED	-9.47%	10.09M
WALGREENS BOOTS ALLIANCE, INC.	-40.48%	13.41B
JD HEALTH INTERNATIONAL INC.	-36.57%	9.99B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-14.86%	7.31B
YIFENG PHARMACY CHAIN CO., LTD.	-0.74%	5.55B
MATSUKIYOCOCOKARA & CO.	-16.04%	5.64B
NAHDI MEDICAL COMPANY	-3.65%	4.55B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+67.41%	4.31B
CLICKS GROUP LIMITED	-6.93%	3.92B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-23.69%	2.99B

Other Drug Retailers